Concepedia

Neil Moss

NM

Statistics

Publications

36

Citations

2.4K

H-Index

24

Active since

1984

Affiliations

Boehringer Ingelheim (United States)(Current)

Boehringer Ingelheim (Canada)

Boehringer Ingelheim (Japan)

Boehringer Ingelheim (Germany)

Boehringer Ingelheim (France)

Neil Moss is an author at Boehringer Ingelheim (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1984–2017

36

Publications

36

Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site

Christopher Pargellis, Liang Tong, Laurie Churchill et al. · Nature Structural Biology · 2002 · 834 citations · Full text

, , +15

Pyrazole Urea-Based Inhibitors of p38 MAP Kinase:  From Lead Compound to Clinical Candidate

John R. Regan, Steffen Breitfelder, Pier F. Cirillo et al. · Journal of Medicinal Chemistry · 2002 · 350 citations · Full text

, , +17

The kinetics of binding to p38 MAP kinase by analogues of BIRB 796

John R. Regan, Christopher A. Pargellis, Pier F. Cirillo et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 111 citations · Full text

, , +12

Structure−Activity Relationships of the p38α MAP Kinase Inhibitor 1-(5-<i>tert</i>-Butyl-2-<i>p</i>-tolyl-2<i>H</i>-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796)

John R. Regan, Alison J. Capolino, Pier F. Cirillo et al. · Journal of Medicinal Chemistry · 2003 · 106 citations · Full text

, , +16

Discovery of 2-Phenylamino-imidazo[4,5-<i>h</i>]isoquinolin-9-ones:  A New Class of Inhibitors of Lck Kinase

Roger J. Snow, Mario Cardozo, Tina M. Morwick et al. · Journal of Medicinal Chemistry · 2002 · 63 citations · Full text

, , +14

1–5 of 36